It's OK to mix and match COVID-19 booster shoots. Which one should I get?

France Nouvelles Nouvelles

It's OK to mix and match COVID-19 booster shoots. Which one should I get?
France Dernières Nouvelles,France Actualités
  • 📰 latimes
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 82%

The FDA and CDC say it's OK to mix and match COVID-19 vaccines and booster shots, and in some cases it's preferred.

Scientists are trying to decide who should be eligible for COVID-19 booster shots, but they’re missing key data that would help them.

These reassuring findings led Dr. Rochelle Walensky, the CDC director, to leave the choice in patients’ hands. The new study includes three groups of 150 fully immunized people — one that got the Pfizer-BioNTech vaccine, one that got the Moderna vaccine, and one that got the Johnson & Johnson shot. Researchers took each group and further divided it into three arms, with 50 people in each. Participants in one arm of each group got boosted with the same product they had originally gotten.

With regard to the Johnson & Johnson vaccine in particular, the data suggest that those who got an initial J&J shot saw their antibody levels rise a bit more after 15 days if they were boosted with the Pfizer-BioNTech or Moderna vaccine than if they got a second dose of J&J.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

latimes /  🏆 11. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

CDC expands eligibility for COVID-19 booster shots, endorses ‘mix and match’ approachCDC expands eligibility for COVID-19 booster shots, endorses ‘mix and match’ approachCDC Director Rochelle Walensky signed off on booster shots for both the Moderna and Johnson & Johnson Covid-19 vaccines.
Lire la suite »

FDA says Pfizer COVID-19 vaccine benefits outweigh risks for kids ages 5 to 11FDA says Pfizer COVID-19 vaccine benefits outweigh risks for kids ages 5 to 11A study released Friday found that kid-size doses of Pfizer’s COVID-19 vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Lire la suite »

People vaccinated against Covid-19 less likely to die from any cause, study findsPeople vaccinated against Covid-19 less likely to die from any cause, study findsPeople who got Covid-19 vaccines were not only less likely to die from the virus, but they were less likely to die from any cause over the following months, researchers reported Friday.
Lire la suite »

Covid-19: Swindon hospital boss wants return of mandatory face masksCovid-19: Swindon hospital boss wants return of mandatory face masksChief executive of Great Western Hospital in Swindon says masks would help alleviate NHS pressure.
Lire la suite »

COVID-19 live updates: Pfizer vaccine highly effective in children 5-11COVID-19 live updates: Pfizer vaccine highly effective in children 5-11The dramatic uptick in hospitalizations seen during the summer's delta surge was fueled by the highly transmissible variant spreading easily among mostly unvaccinated people, the CDC says. Read more:
Lire la suite »

Covid-19: Nightclubs reopen in Republic of Ireland as rules easeCovid-19: Nightclubs reopen in Republic of Ireland as rules easeNightclubs in the Republic of Ireland can operate at full capacity for the first time since March 2020.
Lire la suite »



Render Time: 2025-04-02 02:57:10